![]() |
市場調查報告書
商品編碼
2016105
動脈動脈粥狀硬化斑塊切除術器械市場報告:按產品應用、最終用戶和地區分類(2026-2034 年)Atherectomy Devices Market Report by Product Application, End User, and Region 2026-2034 |
||||||
2025年,全球動脈粥狀硬化斑塊切除術器械市場規模達10.664億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到15.537億美元,2026年至2034年的複合年成長率(CAGR)為4.14%。動脈粥狀硬化切除器械市場成長的主要促進因素包括周邊動脈粥狀硬化斑塊切除術周邊動脈疾病(PAD)盛行率的上升、技術的顯著進步、人口老化、微創手術的普及、醫療基礎設施的改善以及新興國家的醫保報銷政策。
周邊動脈疾病(PAD)病例增加
受人口老化以及糖尿病和肥胖症發病率上升的影響,全球動脈周圍動脈斑塊(PAD)的盛行率不斷增加,推動了動脈粥狀硬化斑塊切除術器械市場的成長。在美國,約有800萬至1200萬人患有PAD,其中50歲以上的人特別突出。在這800萬人中,有650萬人被診斷出患有PAD且年齡超過40歲。動脈動脈粥狀硬化斑塊切除術器械提供了一種微創方法來清除動脈斑塊,使其成為血管介入治療的重要選擇。這些器械可以改善血流,緩解腿痛和疲勞等症狀。透過直接切除或汽化斑塊,這些器械可以恢復動脈通暢性,顯著改善重度PAD患者的預後。
技術進步
動脈粥狀硬化斑塊切除術裝置的關鍵技術創新包括方向可控裝置的出現和高頻旋轉技術的引入,這些創新不斷提高裝置的有效性和安全性。例如,2020 年的一項研究表明,軌道動脈粥狀硬化斑塊切除術(一種去除斑塊的方法)可以有效開通閉塞的下肢動脈,成功率高達 90%,而雷射動脈粥狀硬化斑塊切除術也能達到類似的血流改善效果,成功率為 76%。患者預後的改善以及外科醫生對這些裝置的日益青睞,推動了動脈粥狀硬化斑塊切除術裝置的發展。在一項納入 172 名患者的多中心研究中,Jetstream 裝置的使用證實了 99% 的裝置成功率,臨床評估的 6 個月和 12 個月重組率分別為 15% 和 26%。此外,基於雙功能超音波成像的 1 年再血管再阻塞率為 38%。
進入新興市場
主要市場參與者將目光投向醫療基礎設施正在發展、醫療支出不斷成長的新興經濟體,這為市場中的關鍵參與者創造了新的機會。例如,巴西、俄羅斯、印度、中國和南非(金磚國家)等新興市場正日益影響全球醫療產品和服務的供需趨勢。預計2030年,醫療支出佔GDP的比例將分別達到巴西8.4%、俄羅斯5.2%、印度3.5%、中國5.9%和南非10.4%。更先進治療方法的普及為進入這些市場提供了可能,從而推動了動脈粥狀硬化斑塊切除術設備在全球的推廣應用。
The global atherectomy devices market size reached USD 1,066.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,553.7 Million by 2034, exhibiting a growth rate (CAGR) of 4.14% during 2026-2034. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.
Rising Cases of Peripheral Artery Disease (PAD)
The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.
Technological Advancements
Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.
Expansion into Emerging Markets
Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.
The publisher provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2026-2034. Our report has categorized the market based on product, application, and end user.
Directional Atherectomy Devices accounts for the majority of the market share
Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.
Peripheral Vascular accounts for the majority of the market share
The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.
Hospitals accounts for the majority of the market share
Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.
North America dominates the market
The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.
North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.